Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

April 01, 1991; Volume 39,Issue 4
  • You have access
    Photoaffinity labeling of the dopamine reuptake carrier protein with 3-azido[3H]GBR-12935.
    S P Berger, R E Martenson, P Laing, A Thurkauf, B Decosta, K C Rice and S M Paul
    Molecular Pharmacology April 1991, 39 (4) 429-435;
  • You have access
    Naturally occurring opioid receptor agonists stimulate adenylate cyclase activity in rat olfactory bulb.
    P Onali and M C Olianas
    Molecular Pharmacology April 1991, 39 (4) 436-441;
  • You have access
    Differentiation of human promonocytic leukemia U-937 cells with DNA topoisomerase II inhibitors: induction of vimentin gene expression.
    C Rius, A R Zorrilla, C Cabañas, F Mata, C Bernabeu and P Aller
    Molecular Pharmacology April 1991, 39 (4) 442-448;
  • You have access
    Action of 9-beta-D-arabinofuranosyl-2-fluoroadenine on RNA metabolism.
    P Huang and W Plunkett
    Molecular Pharmacology April 1991, 39 (4) 449-455;
  • You have access
    Ascorbic acid deficiency decreases specific forms of cytochrome P-450 in liver microsomes of guinea pigs.
    Y Kanazawa, M Kitada, T Mori, Y Inukai, S Imaoka, Y Funae and T Kamataki
    Molecular Pharmacology April 1991, 39 (4) 456-460;
  • You have access
    Expression of tandem glutathione S-transferase recombinant genes in COS cells for analysis of efficiency of protein expression and associated drug resistance.
    T H Manoharan, P J Welch, A M Gulick, R B Puchalski, A L Lathrop and W E Fahl
    Molecular Pharmacology April 1991, 39 (4) 461-467;
  • You have access
    Regulation of cytochrome P450IIC12 expression by interleukin-1 alpha, interleukin-6, and dexamethasone.
    K Wright and E T Morgan
    Molecular Pharmacology April 1991, 39 (4) 468-474;
  • You have access
    Genistein, a protein tyrosine kinase inhibitor, inhibits thromboxane A2-mediated human platelet responses.
    S Nakashima, T Koike and Y Nozawa
    Molecular Pharmacology April 1991, 39 (4) 475-480;
  • You have access
    Monovalent cation and amiloride analog modulation of adrenergic ligand binding to the unglycosylated alpha 2B-adrenergic receptor subtype.
    A L Wilson, K Seibert, S Brandon, E J Cragoe and L E Limbird
    Molecular Pharmacology April 1991, 39 (4) 481-486;
  • You have access
    Selective cellular depletion of mitochondrial DNA by the polyamine analog N1,N12-bis(ethyl)spermine and its relationship to polyamine structure and function.
    P M Vertino, T A Beerman, E J Kelly, R J Bergeron and C W Porter
    Molecular Pharmacology April 1991, 39 (4) 487-494;
  • You have access
    2,3,7,8-Tetrachlorodibenzo-p-dioxin stimulation of tyrosine phosphorylation in B lymphocytes: potential role in immunosuppression.
    G C Clark, J A Blank, D R Germolec and M I Luster
    Molecular Pharmacology April 1991, 39 (4) 495-501;
  • You have access
    Theoretical study of the flexibility and solution conformation of the cyclic opioid peptides [D-Pen2,D-Pen5]enkephalin and [D-Pen2,L-Pen5]enkephalin.
    C Chew, H O Villar and G H Loew
    Molecular Pharmacology April 1991, 39 (4) 502-510;
  • You have access
    Directed shift of fatty acids from phospholipids to triacylglycerols in HL-60 cells induced by nanomolar concentrations of triethyl lead chloride: involvement of a pertussis toxin-sensitive pathway.
    H F Krug and H Culig
    Molecular Pharmacology April 1991, 39 (4) 511-516;
  • You have access
    Mechanism of A2 adenosine receptor activation. I. Blockade of A2 adenosine receptors by photoaffinity labeling.
    M J Lohse, K N Klotz and U Schwabe
    Molecular Pharmacology April 1991, 39 (4) 517-523;
  • You have access
    Mechanism of activation of A2 adenosine receptors. II. A restricted collision-coupling model of receptor-effector interaction.
    W Gross and M J Lohse
    Molecular Pharmacology April 1991, 39 (4) 524-530;
  • You have access
    Regulation of dopamine D2 receptors in a novel cell line (SUP1).
    K J Ivins, R R Luedtke, R P Artymyshyn and P B Molinoff
    Molecular Pharmacology April 1991, 39 (4) 531-539;
  • You have access
    Actions of cardiac drugs on a calcium-dependent potassium channel in hippocampal neurons.
    J G McLarnon and X P Wang
    Molecular Pharmacology April 1991, 39 (4) 540-546;
  • You have access
    Diacylglycerol overcomes aspirin inhibition of platelets: evidence for a necessary role for diacylglycerol accumulation in platelet activation.
    M H Werner, L Senzel, A Bielawska, W Khan and Y A Hannun
    Molecular Pharmacology April 1991, 39 (4) 547-556;
  • You have access
    Alpha-difluoromethylornithine inhibits bone resorption in vitro without decreasing beta-glucuronidase release.
    P H Stern, R C Lucas and J Seidenfeld
    Molecular Pharmacology April 1991, 39 (4) 557-562;
  • You have access
    In vitro model for intrinsic drug resistance: effects of protein kinase C activators on the chemosensitivity of cultured human colon cancer cells.
    Z Y Dong, N E Ward, D Fan, K P Gupta and C A O'Brian
    Molecular Pharmacology April 1991, 39 (4) 563-569;
  • You have access
    Regulation of dopamine D2 receptors by sodium and pH.
    K A Neve
    Molecular Pharmacology April 1991, 39 (4) 570-578;
  • You have access
    DuP 753 can antagonize the effects of angiotensin II in rat liver.
    P H Bauer, A T Chiu and J C Garrison
    Molecular Pharmacology April 1991, 39 (4) 579-585;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 39, Issue 4
1 Apr 1991
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics